177 related articles for article (PubMed ID: 16702043)
1. Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism.
Kranzhofer R; Ruef J
Platelets; 2006 May; 17(3):163-9. PubMed ID: 16702043
[TBL] [Abstract][Full Text] [Related]
2. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting.
Censarek P; Steger G; Paolini C; Hohlfeld T; Grosser T; Zimmermann N; Fleckenstein D; Schrör K; Weber AA
Thromb Haemost; 2007 Dec; 98(6):1309-15. PubMed ID: 18064329
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
6. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
Halushka MK; Walker LP; Halushka PV
Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Gao F; Wang ZX; Men JL; Ren J; Wei MX
Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
11. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
[TBL] [Abstract][Full Text] [Related]
12. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
13. Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms.
Takahashi S; Ushida M; Komine R; Shimodaira A; Uchida T; Ishihara H; Shibano T; Watanabe G; Ikeda Y; Murata M
Thromb Res; 2008; 121(4):509-17. PubMed ID: 17631383
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
15. The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin.
Abderrazek F; Chakroun T; Addad F; Dridi Z; Gerotziafas G; Gamra H; Hassine M; Elalamy I
Thromb Res; 2010 Jun; 125(6):e265-8. PubMed ID: 20138334
[TBL] [Abstract][Full Text] [Related]
16. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
[TBL] [Abstract][Full Text] [Related]
17. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
Lordkipanidzé M; Diodati JG; Turgeon J; Schampaert E; Palisaitis DA; Pharand C
Int J Cardiol; 2010 Aug; 143(1):43-50. PubMed ID: 19215991
[TBL] [Abstract][Full Text] [Related]
18. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.
Mattiello T; Guerriero R; Lotti LV; Trifirò E; Felli MP; Barbarulo A; Pucci B; Gazzaniga P; Gaudio C; Frati L; Pulcinelli FM
J Am Coll Cardiol; 2011 Aug; 58(7):752-61. PubMed ID: 21816313
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
[TBL] [Abstract][Full Text] [Related]
20. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
Evangelista V; Manarini S; Di Santo A; Capone ML; Ricciotti E; Di Francesco L; Tacconelli S; Sacchetti A; D'Angelo S; Scilimati A; Sciulli MG; Patrignani P
Circ Res; 2006 Mar; 98(5):593-5. PubMed ID: 16484611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
